TY - JOUR
T1 - Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma
AU - Yatsuoka, Toshimasa
AU - Sunamura, Makoto
AU - Furukawa, Toru
AU - Fukushige, Shinichi
AU - Yokoyama, Tadaaki
AU - Inoue, Hiroko
AU - Shibuya, Kazuhiko
AU - Takeda, Kazunoriu
AU - Matsuno, Seiki
AU - Horii, Akira
N1 - Funding Information:
We are grateful to Dr. Barbara Lee Smith Pierce (the Life Science Coordinator for the University of Maryland Asian Division) for editorial work in the preparation of this manuscript. This work was supported by Japanese Ministries of Education, Science, Sports and Culture, and Health and Welfare, Vehicle Racing Commemorative Foundation, Mitsui Life Social Welfare Foundation, and Pancreas Research Foundation of Japan.
PY - 2000
Y1 - 2000
N2 - OBJECTIVE: Pancreatic cancer is one of the diseases with the poorest prognosis, but the associated genetic alterations are not yet well understood. The genetic alterations reported to date in pancreatic cancer include frequent mutations of the KRAS, TP53, p16, and SMAD4 genes. Mutation of the TP53 gene was reported to be associated with a poor prognosis. In this study, we analyzed the association of toss of heterozygosity (LOH) with clinicopathological features to attempt to devise effective methods in the future for clinically applying our results to diagnosis and treatment. METHODS: A total of 55 tumors from patients with primary pancreatic ductal carcinomas (34 men and 21 women, mean average age 63.9 yr) in which all the relevant clinical and pathological data were available were analyzed. A total of 46 cases were surgically resected, and nine cases were not. Tumor cells as well as corresponding normal cells were collected by microdissection under a microscope, and DNAs were purified. Allelotype analysis was performed by the PCR-based method, and the results were statistically analyzed. RESULTS: LOH of ≥30% were observed on chromosome arms 17p (47%, 17/36), 9p (45%, 14/31), 18q (43%, 15/35), 12q (34%, 10/29), and 6q (30%, 10/33). LOH of 12q, 17p, and 18q were significantly associated with a poor prognosis. Concordant losses of 6q with 17p and 18q were significantly associated with a poor prognosis. Concordant losses of 6q with 17p and of 12q with 18q were also found. CONCLUSIONS: Because LOH of 12q, 17p, and 18q are significantly associated with a poor prognosis, mutation of the putative tumor suppressor genes on these chromosome arms may play significant roles in the disease progression. Concordant losses of 6q with 17p and of 12q with 18q suggest that protein products of putative tumor suppressor genes on 6q and 12q may function in association with TP53 and SMAD4, respectively. (C) 2000 by Am. Coll. of Gastroenterology.
AB - OBJECTIVE: Pancreatic cancer is one of the diseases with the poorest prognosis, but the associated genetic alterations are not yet well understood. The genetic alterations reported to date in pancreatic cancer include frequent mutations of the KRAS, TP53, p16, and SMAD4 genes. Mutation of the TP53 gene was reported to be associated with a poor prognosis. In this study, we analyzed the association of toss of heterozygosity (LOH) with clinicopathological features to attempt to devise effective methods in the future for clinically applying our results to diagnosis and treatment. METHODS: A total of 55 tumors from patients with primary pancreatic ductal carcinomas (34 men and 21 women, mean average age 63.9 yr) in which all the relevant clinical and pathological data were available were analyzed. A total of 46 cases were surgically resected, and nine cases were not. Tumor cells as well as corresponding normal cells were collected by microdissection under a microscope, and DNAs were purified. Allelotype analysis was performed by the PCR-based method, and the results were statistically analyzed. RESULTS: LOH of ≥30% were observed on chromosome arms 17p (47%, 17/36), 9p (45%, 14/31), 18q (43%, 15/35), 12q (34%, 10/29), and 6q (30%, 10/33). LOH of 12q, 17p, and 18q were significantly associated with a poor prognosis. Concordant losses of 6q with 17p and 18q were significantly associated with a poor prognosis. Concordant losses of 6q with 17p and of 12q with 18q were also found. CONCLUSIONS: Because LOH of 12q, 17p, and 18q are significantly associated with a poor prognosis, mutation of the putative tumor suppressor genes on these chromosome arms may play significant roles in the disease progression. Concordant losses of 6q with 17p and of 12q with 18q suggest that protein products of putative tumor suppressor genes on 6q and 12q may function in association with TP53 and SMAD4, respectively. (C) 2000 by Am. Coll. of Gastroenterology.
UR - http://www.scopus.com/inward/record.url?scp=0033869735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033869735&partnerID=8YFLogxK
U2 - 10.1016/S0002-9270(00)00963-1
DO - 10.1016/S0002-9270(00)00963-1
M3 - Article
C2 - 10950061
AN - SCOPUS:0033869735
SN - 0002-9270
VL - 95
SP - 2080
EP - 2085
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 8
ER -
